| Literature DB >> 34911515 |
Hashim Talib Hashim1, Mustafa Ahmed Ramadhan1, Kabas Monther Theban1, John Bchara2, Ahed El-Abed-El-Rassoul3, Jaffer Shah4.
Abstract
BACKGROUND: Breast cancer is one of the most common cancers among women worldwide and the leading cause of death among Iraqi women. Breast cancer cases in Iraq were found to have increased from 26.6/100,000 in 2000 to 31.5/100,000 in 2009. The present study aims to assess the established risk factors of breast cancer among Iraqi women and to highlight strategies that can aid in reducing the incidence.Entities:
Keywords: 5 years' risk; Assessment; BCRAT; Breast cancer; Gail Model; Lifetime risk
Mesh:
Year: 2021 PMID: 34911515 PMCID: PMC8672597 DOI: 10.1186/s12905-021-01557-1
Source DB: PubMed Journal: BMC Womens Health ISSN: 1472-6874 Impact factor: 2.742
Characteristics of study participants
| Frequency | Percentage | |
|---|---|---|
| Yes | 473 | 43.3 |
| No | 614 | 56.2 |
| Unknown | 6 | 0.5 |
| Yes | 1006 | 92 |
| No | 87 | 8 |
| Illiterate | 211 | 19.3 |
| Primary | 252 | 23.1 |
| Secondary | 293 | 26.8 |
| University | 337 | 30.8 |
| No children | 131 | 12 |
| 1–2 children | 162 | 14.8 |
| 3–5 children | 476 | 43.5 |
| More than 5 | 324 | 29.6 |
| No birth | 130 | 11.9 |
| Less than 20 years | 346 | 31.7 |
| 20–24 years | 351 | 32.1 |
| 25–29 years | 195 | 17.8 |
| 30–39 years | 69 | 6.3 |
| More than 40 years | 2 | 0.2 |
| Yes | 846 | 77.4 |
| No | 247 | 22.6 |
| Yes | 544 | 49.8 |
| No | 549 | 50.2 |
| 7–11 years | 113 | 10.3 |
| 12–13 years | 671 | 61.4 |
| More than 13 years | 309 | 28.3 |
| Premenopausal | 741 | 67.8 |
| Postmenopausal | 352 | 32.2 |
| Arabic | 881 | 80.6 |
| Kurdish | 137 | 12.5 |
| Turkmen | 75 | 6.9 |
| Low (Less than 250 IQD) | 224 | 20.5 |
| Moderate (250–Million IQD) | 615 | 56.3 |
| High (More than Million IQD) | 254 | 23.2 |
| Yes | 57 | 5.2 |
| No | 1036 | 94.8 |
| Never | 648 | 59.3 |
| Once weekly | 188 | 17.2 |
| Twice weekly | 116 | 10.6 |
| More than twice weekly | 141 | 12.9 |
| No Biopsy | 1058 | 96.8 |
| One Biopsy (Without Hyperplasia) | 35 | 3.2 |
| No one | 907 | 83 |
| One relative | 120 | 11 |
| More than one relative | 66 | 6 |
| Housewife | 736 | 67.3 |
| Others | 357 | 32.7 |
The governorates of the participants
| Frequency | Percentage | |
|---|---|---|
| Anbar | 46 | 4.2 |
| Babil | 45 | 4.1 |
| Baghdad | 191 | 17.5 |
| Basra | 97 | 8.9 |
| Dhi Qar | 75 | 6.9 |
| Diyala | 47 | 4.3 |
| Dohuk | 44 | 4 |
| Erbil | 53 | 4.8 |
| Karbala | 33 | 3 |
| Kirkuk | 58 | 5.3 |
| Maysan | 52 | 4.8 |
| Muthanna | 40 | 3.7 |
| Najaf | 62 | 5.7 |
| Nineveh | 60 | 5.5 |
| Qadisiyyah | 53 | 4.8 |
| Saladin | 51 | 4.7 |
| Sulaymaniyah | 37 | 3.4 |
| Wasit | 49 | 4.5 |
| Total | 1093 | 100 |
The 5–year risk frequencies
| Frequency | Percentage | |
|---|---|---|
| Low | 823 | 75.3 |
| High | 270 | 24.7 |
| Total | 1093 | 100 |
| Low | 707 | 64.7 |
| Moderate | 331 | 30.3 |
| High | 55 | 5.0 |
| Total | 1093 | 100.0 |
Risk assessment using the Gail model
| 5-year risk | Lifetime risk | ||||
|---|---|---|---|---|---|
| Low | High | Low | Moderate | High | |
| Yes | 364 (44.2%) | 109 (40.3%) | 295 (41.7%) | 151 (45.7%) | 27 (49%) |
| No | 455 (55.2%) | 159 (59%) | 409 (57.8%) | 177 (53.4%) | 28 (51%) |
| Unknown | 4 (0.6%) | 2 (0.7%) | 3 (0.5%) | 3 (0.9%) | (0%) |
| Yes | 741 (90%) | 265 (98%) | 625 (88.4%) | 327 (98.8%) | 54 (98.2%) |
| No | 82 (10%) | 5 (2%) | 82 (11.6%) | 4 (1.2%) | (1.8%) |
| Illiterate | 114 (13.8%) | 97 (36%) | 131 (18.5%) | 73 (22%) | 7 (12.8%) |
| Primary | 191 (23.2%) | 61 (22.6%) | 127 (18%) | 113 (34.1%) | 12 (21.8) |
| Secondary | 238 (29%) | 55 (20.3%) | 177 (25%) | 98 (29.6%) | 18 (32.7%) |
| University | 280 (34%) | 57 (21.1%) | 272 (38.5%) | 47 (14.3%) | (32.7%) |
| No children | 129 (15.6%) | 2 (0.7%) | 130 (18.3%) | 1 (0.3%) | 0 (0%) |
| 1–2 children | 127 (15.4%) | 35 (13%) | 98 (13.8%) | 55 (16.6%) | 9 (16.3%) |
| 3–5 children | 375 (45.5%) | 101 (37.4%) | 303 (42.8%) | 141 (42.5%) | 32 (58.1%) |
| More than 5 | 192 (23.5%) | 132 (48.9%) | 176 (25.1%) | 134 (40.6%) | (25.6%) |
| No birth | 128 (15.6%) | 2 (0.7%) | 129 (18.2%) | 1 (0.3%) | 0 (0%) |
| Less than 20 years | 181 (22%) | 165 (61%) | 70 (10%) | 255 (77%) | 21 (38.3%) |
| 20–24 years | 296 (36%) | 55 (20.3%) | 283 (40%) | 43 (13%) | 25 (45.4%) |
| 25–29 years | 169 (20.5%) | 26 (9.6%) | 169 (24%) | 18 (5.4%) | 8 (14.5%) |
| 30–39 years | 47 (5.7%) | 22 (8.4%) | 54 (7.6%) | 14 (4.3%) | 1 (1.8%) |
| More than 40 years | 2 (0.2%) | 0 (0%) | 2 (0.2%) | 0 (0%) | (0%) |
| Yes | 617 (75%) | 229 (84.8%) | 515 (72.9%) | 289 (87.4%) | 42 (76.4%) |
| No | 206 (25%) | 41 (15.2%) | 192 (27.1%) | 42 (12.6%) | (23.6%) |
| Yes | 424 (52.6%) | 120 (44.4%) | 314 (44.4%) | 201 (60.7%) | 29 (52.8%) |
| No | 399 (48.4%) | 150 (55.6%) | 393 (55.6%) | 130 (39.3%) | (47.2%) |
| 7–11 years | 63 (7.7%) | 50 (18.2%) | 52 (7.3%) | 47 (14.1%) | 14 (25.6%) |
| 12–13 years | 496 (60.2%) | 175 (64.8%) | 417 (59%) | 219 (66.1%) | 35 (63.4%) |
| More than 13 years | 264 (32.1%) | 45 (17%) | 238 (33.7%) | 65 (19.8%) | (11%) |
| Premenopausal | 179 (21.7%) | 173 (21%) | 445 (63%) | 256 (77.4%) | 40 (72.8%) |
| Postmenopausal | 644 (78.3%) | 97 (79%) | 262 (37%) | 75 (22.6%) | (27.2%) |
| Arabic | 665 (80.8%) | 216 (80%) | 564 (79.7%) | 271 (82%) | 46 (83.6%) |
| Kurdish | 99 (12%) | 38 (14%) | 89 (12.5%) | 42 (12.6%) | 6 (11%) |
| Turkmen | 59 (7.2%) | 16 (6%) | 54 (7.8%) | 18 (5.4%) | (5.4%) |
| Low (Less than 250 IQD) | 164 (20%) | 60 (22%) | 130 (18.5%) | 81 (24.5%) | 13 (23.8%) |
| Moderate (250–Million IQD) | 459 (55.7%) | 156 (58%) | 385 (54.4%) | 198 (59.8%) | 32 (58.1%) |
| High (More than Million IQD) | 200 (24.3%) | 54 (20%) | 192 (27.1%) | 52 (15.7%) | (18.1%) |
| Yes | 32 (4%) | 25 (9%) | 40 (5.7%) | 12 (3.7%) | 5 (9%) |
| No | 791 (96%) | 245 (91%) | 667 (94.3%) | 319 (96.3%) | (91%) |
| Never | 473 (57.4%) | 175 (65%) | 421 (59.5%) | 201 (60.7%) | 26 (47.2%) |
| Once weekly | 146 (17.7%) | 42 (16%) | 120 (17%) | 58 (17.5%) | 10 (18.1%) |
| Twice weekly | 85 (10.4%) | 31 (11%) | 80 (11.3%) | 25 (7.5%) | 11 (20.2%) |
| More than twice weekly | 119 (14.5%) | 22 (8%) | 86 (12.2%) | 47 (14.3%) | (14.5%) |
| No biopsy | 804 (97.7%) | 254 (94%) | 16 (2.3%) | 13 (4%) | 6 (11%) |
| One biopsy (Without hyperplasia) | 19 (2.3%) | 16 (6%) | 691 (97.7%) | 318 (96%) | (39%) |
| No one | 745 (90.5%) | 162 (60%) | 670 (94.7%) | 235 (71%) | 2 (3.7%) |
| One relative | 68 (8.25%) | 52 (19.25%) | 31 (4.3%) | 88 (26.5) | 1 (1.8%) |
| More than one relative | 10 (1.25%) | 56 (20.75%) | 6 (1%) | 8 (2.5%) | 52 (94.5%) |
Linear regression results for the 5-year and lifetime risks
| R-value | R2-value (%) | Standard error | ||
|---|---|---|---|---|
| Age | 0.615 | 37.8 | 0.8156 | < 0.001 |
| Age of menarche | 0.23 | 5.3 | 1.0065 | < 0.001 |
| Age at first birth | 0.027 | 0.1 | 1.03387 | 0.369 |
| Number of biopsies | 0.124 | 1.5 | 1.02626 | < 0.001 |
| Race | 0.013 | 0 | 1.03417 | 0.676 |
| First degree relatives | 0.546 | 29.8 | 0.8666 | < 0.001 |
| Menopause | 0.459 | 21.1 | 0.9189 | < 0.001 |
| Using of contraceptives | 0.044 | 0.2 | 1.033253 | 0.145 |
| Monthly income | 0.025 | 0.1 | 1.03393 | 0.406 |
| Smoking | 0.158 | 2.5 | 1.021231 | 0 |
| Physical activity | 0.055 | 0.3 | 1.032702 | 0.07 |
| Age | 0.336 | 11.3 | 6.4536 | 0 |
| Age of menarche | 0.202 | 4.1 | 6.7098 | 0.003 |
| Age at first birth | 0.177 | 3.1 | 6.7427 | 0.01 |
| Number of biopsies | 0.002 | 0 | 6.851421 | 0.978 |
| Race | 0.047 | 0.2 | 6.84376 | 0.497 |
| First degree relatives | 0.753 | 56.8 | 4.50556 | 0 |
| Menopause | 0.280 | 7.8 | 6.57707 | 0 |
| Using of contraceptives | 0.065 | 0.4 | 6.83704 | 0.353 |
| Monthly income | 0.081 | 0.7 | 6.828912 | 0.245 |
| Smoking | 0.079 | 0.6 | 6.829924 | 0.256 |
| Physical activity | 0.067 | 0.4 | 6.836088 | 0.337 |
Gail's breast cancer risk in various countries
| Country | Year | Sample size | Age | 5–year risk | Lifetime risk |
|---|---|---|---|---|---|
| USA [ | 1989 | 4496 | > 50 | 1.02 | 11.21 |
| USA [ | 2001 | 319 | ≥ 35 | 1.67 | – |
| USA [ | 2004 | 254 | > 40 | 1.5 | 8.4 |
| USA [ | 2005 | 8388 | > 18 | 0.8 | 8 |
| USA [ | 2006 | 99 | ≥ 35 | 4.13 | 23.5 |
| USA [ | 2009 | 883 | > 40 | 0.88 | – |
| USA [ | 2016 | 124 | > 50 | 1.67 | – |
| Iraq (Baghdad) [ | 2016 | 250 | ≥ 35 | 0.95 | 11.3 |
| Iraq (This Study) | 2019 | 1093 | ≥ 35 | 1.33 | 13.36 |
| Iran [ | 2008 | 2000 | ≥ 35 | 0.92 | 9.14 |
| Iran [ | 2012 | 314 | ≥ 35 | 0.8 | 9 |
| Iran [ | 2016 | 560 | ≥ 35 | 0.6 | 8.9 |
| Iran [ | 2016 | 3847 | ≥ 35 | 1.61 | 11.71 |
| Turkey [ | 2010 | 650 | ≥ 35 | 1.67 | 7.7 |
| Turkey [ | 2011 | 415 | > 20 | 1.7 | 15 |
| Turkey [ | 2015 | 231 | ≥ 35 | 0.88 | 9.37 |
| United Kingdom [ | 2013 | 355 | > 46 | 1.5 | 9 |
| Bulgaria [ | 2009 | 315 | ≥ 35 | 1.51 | – |
| India [ | 2013 | 200 | ≥ 35 | – | 7.8 |
| Korea [ | 2013 | 3789 | < 50 | 0.44 | 2.24 |
| Czech Republic [ | 2006 | 4598 | ≥ 35 | 1.37 | 8.02 |
| Qatar [ | 2016 | 1488 | ≥ 35 | 1.12 | 10.57 |
| Saudi Arabia [ | 2017 | 180 | ≥ 35 | 0.87 | 9.6 |
| Bahrain [ | 2013 | 300 | ≥ 35 | 0.7 | 9.3 |
Fig. 15-year and lifetime risk distribution among the governorates